Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Amman Mineral Internasional Tbk (AMMN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Amman Mineral Internasional TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Amman Mineral Internasional Tbk dan Brigit Biofarmaka Teknologi Tbk.: Amman Mineral Internasional Tbk diperdagangkan di Rp4.220 (kapitalisasi pasar 316,9 T, volume 24 jam 47,61 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Amman Mineral Internasional Tbk jauh lebih besar — sekitar 1924,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Amman Mineral Internasional Tbk lebih aktif diperdagangkan (47,61 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.

AMMNOBAT
Kapitalisasi Pasar
316,9 T164,65 M
Volume
47,61 jt187,4 rb
Lot
476,12 rb1,87 rb
Perputaran
203,68 M44,35 jt
Harga Rata-rata
4.277,91236,67
Nilai Transaksi
203,68 M44,35 jt
Harga Ekuilibrium Indikatif
4.220242
Volume Ekuilibrium Indikatif
21,57 rb500

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

AMMN
Lihat detail
OBAT
Lihat detail

Tentang Amman Mineral Internasional Tbk

PT Amman Mineral Internasional Tbk (the Company) was established on September 29, 2015 under the name PT Amman Mineral Internasional and based on Notarial Deed No. 30 of Martina, S.H., notary in Jakarta. The Company was established in connection with the acquisition of AMNT, formerly known as PT Newmont Nusa Tenggara (PTNNT). PTNNT runs its operations under the ownership of a consortium of investors, including Nusa Tenggara Partnership B.V. (NTPBV) which is indirectly owned by Newmont Corporation (Newmont) and Sumitomo Corporation (Sumitomo), PT Multi Daerah Bersaing (PTMDB), PT Indonesia Masbaga Investama (PTIMI), and PT Pukuafu Indah (PTPI). On November 2, 2016, the Company acquired 82.2% shares of PTNNT from NTPBV, PTMDB, and PTIMI, and changed PTNNTs name to AMNT (Acquisition). In December 2020, the Company acquired the remaining outstanding shares of AMNT from PTPI, where the Company is until the date of this Prospectus is issued, owns 99.99% of AMNTs outstanding shares. The remaining 0.01% outstanding shares of AMNT are owned by PT AP Investment (PTAPI), one of the Companys shareholders. Established in 1986, PTNNT began development and construction of the Batu Hijau mine in 1997 and has been producing commodities in the form of copper concentrate which also contains gold and silver as minerals followers since 2000.

Selengkapnya di halaman AMMN

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT